506 related articles for article (PubMed ID: 38580979)
1. The cell biology of HIV-1 latency and rebound.
Mbonye U; Karn J
Retrovirology; 2024 Apr; 21(1):6. PubMed ID: 38580979
[TBL] [Abstract][Full Text] [Related]
2. Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure.
Duggan NN; Dragic T; Chanda SK; Pache L
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140676
[TBL] [Abstract][Full Text] [Related]
3. Irreversible Loss of HIV-1 Proviral Competence in Myeloid Cells upon Suppression of NF-κB Activity.
Peters RJ; Stevenson M
J Virol; 2022 Jun; 96(12):e0048422. PubMed ID: 35604217
[TBL] [Abstract][Full Text] [Related]
4. A macrophage-cell model of HIV latency reveals the unusual importance of the bromodomain axis.
Kisaka JK; Rauch D; Griffith M; Kyei GB
Virol J; 2024 Apr; 21(1):80. PubMed ID: 38581045
[TBL] [Abstract][Full Text] [Related]
5. New latency-promoting agents for a block-and-lock functional cure strategy.
Pellaers E; Denis A; Debyser Z
Curr Opin HIV AIDS; 2024 May; 19(3):95-101. PubMed ID: 38457209
[TBL] [Abstract][Full Text] [Related]
6. Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversal.
Moran JA; Ranjan A; Hourani R; Kim JT; Wender PA; Zack JA; Marsden MD
Virology; 2023 Apr; 581():8-14. PubMed ID: 36842270
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Remission: Accelerating the Path to Permanent HIV-1 Silencing.
Lyons DE; Kumar P; Roan NR; Defechereux PA; Feschotte C; Lange UC; Murthy N; Sameshima P; Verdin E; Ake JA; Parsons MS; Nath A; Gianella S; Smith DM; Kallas EG; Villa TJ; Strange R; Mwesigwa B; Furler O'Brien RL; Nixon DF; Ndhlovu LC; Valente ST; Ott M
Viruses; 2023 Oct; 15(11):. PubMed ID: 38005849
[TBL] [Abstract][Full Text] [Related]
8. Mitotic deacetylase complex (MiDAC) recognizes the HIV-1 core promoter to control activated viral gene expression.
Wilhelm E; Poirier M; Da Rocha M; Bédard M; McDonald PP; Lavigne P; Hunter CL; Bell B
PLoS Pathog; 2024 May; 20(5):e1011821. PubMed ID: 38781120
[TBL] [Abstract][Full Text] [Related]
9. "Block and lock" viral integration sites in persons with drug-free control of HIV-1 infection.
Bone B; Lichterfeld M
Curr Opin HIV AIDS; 2024 May; 19(3):110-115. PubMed ID: 38457193
[TBL] [Abstract][Full Text] [Related]
10. Targeting noncoding RNAs to reactivate or eliminate latent HIV reservoirs.
Beliakova-Bethell N
Curr Opin HIV AIDS; 2024 Mar; 19(2):47-55. PubMed ID: 38169367
[TBL] [Abstract][Full Text] [Related]
11. Integrated Single-cell Multiomic Analysis of HIV Latency Reversal Reveals Novel Regulators of Viral Reactivation.
Ashokkumar M; Mei W; Peterson JJ; Harigaya Y; Murdoch DM; Margolis DM; Kornfein C; Oesterling A; Guo Z; Rudin CD; Jiang Y; Browne EP
Genomics Proteomics Bioinformatics; 2024 May; 22(1):. PubMed ID: 38902848
[TBL] [Abstract][Full Text] [Related]
12. Single-cell epigenetic, transcriptional, and protein profiling of latent and active HIV-1 reservoir revealed that IKZF3 promotes HIV-1 persistence.
Wei Y; Davenport TC; Collora JA; Ma HK; Pinto-Santini D; Lama J; Alfaro R; Duerr A; Ho YC
Immunity; 2023 Nov; 56(11):2584-2601.e7. PubMed ID: 37922905
[TBL] [Abstract][Full Text] [Related]
13. HIV Expression in Infected T Cell Clones.
Rausch JW; Parvez S; Pathak S; Capoferri AA; Kearney MF
Viruses; 2024 Jan; 16(1):. PubMed ID: 38257808
[TBL] [Abstract][Full Text] [Related]
14. IL-15 and N-803 for HIV Cure Approaches.
Howard JN; Bosque A
Viruses; 2023 Sep; 15(9):. PubMed ID: 37766318
[TBL] [Abstract][Full Text] [Related]
15. Targeted shock-and-kill HIV-1 gene therapy approach combining CRISPR activation, suicide gene tBid and retargeted adenovirus delivery.
Klinnert S; Schenkel CD; Freitag PC; Günthard HF; Plückthun A; Metzner KJ
Gene Ther; 2024 Mar; 31(3-4):74-84. PubMed ID: 37558852
[TBL] [Abstract][Full Text] [Related]
16. The sounds of silencing: dynamic epigenetic control of HIV latency.
Nguyen K; Karn J
Curr Opin HIV AIDS; 2024 May; 19(3):102-109. PubMed ID: 38547337
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Proviral Genome Engineering with CRISPR-Cas9 for Mechanistic Studies.
Hyder U; Shukla A; Challa A; D'Orso I
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400062
[TBL] [Abstract][Full Text] [Related]
18. A Canadian Survey of Research on HIV-1 Latency-Where Are We Now and Where Are We Heading?
Abdalla AL; Guajardo-Contreras G; Mouland AJ
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400005
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 subtypes and latent reservoirs.
Ranga U; Panchapakesan A; Saini C
Curr Opin HIV AIDS; 2024 Mar; 19(2):87-92. PubMed ID: 38169308
[TBL] [Abstract][Full Text] [Related]
20. Virally Suppressed People Living with HIV Who Use Opioids Have Diminished Latency Reversal.
Basukala B; Rossi S; Bendiks S; Gnatienko N; Patts G; Krupitsky E; Lioznov D; So-Armah K; Sagar M; Cheng C; Henderson AJ
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
